Akouos, Inc.
METHODS OF TREATING CLRN1-ASSOCIATED HEARING LOSS AND/OR VISION LOSS

Last updated:

Abstract:

Provided herein are compositions that include a single nucleic acid vector or two different nucleic acid vectors, and the use of these compositions to treat hearing loss and/or vision loss in a subject.

Status:
Application
Type:

Utility

Filling date:

25 Jun 2019

Issue date:

9 Sep 2021